Adipokine levels in subretinal fluid from patients with rhegmatogenous retinal detachment

Experimental Eye Research

Volumn 94, Issue 1, 2012, Pages 56-62

  Ricker, Lukas J A G ^a,b   Kijlstra, Aize ^a   Kessels, Alfons G H ^a   de Jager, Wilco ^c   Hendrikse, Fred ^a   La Heij, Ellen C ^a,c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b European Graduate School For Neuroscience   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Adipokines; Cytokines; Proliferative vitreoretinopathy; Retinal detachment; Scleral buckling surgery; Subretinal fluid; TIMP 1

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ADIPSIN; CATHEPSIN S; CHEMERIN; LEPTIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA DETACHMENT SURGERY; RHEGMATOGENOUS RETINA DETACHMENT; SUBRETINAL FLUID; VITREORETINOPATHY;

ADIPOKINES; ADULT; AGED; CATHEPSINS; ENDOTAMPONADE; FEMALE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; RECURRENCE; RETINAL DETACHMENT; SCLERAL BUCKLING; SUBRETINAL FLUID; TISSUE INHIBITOR OF METALLOPROTEINASE-1; VITRECTOMY; VITREORETINOPATHY, PROLIFERATIVE;

EID: 84855837240     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2011.11.006     Document Type: Article

References (53)

1. Alexander J.P., Bradley J.M.B., Gabourel J.D., Acott T.S. Expression of matrix metalloproteinases and inhibitor by human retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 1990, 31:2520-2528.
2. Antoniades C., Antonopoulos A.S., Tousoulis D., Stefanadis C. Adiponectin: from obesity to cardiovascular disease. Obes. Rev. 2009, 10:269-279.
3. Barbier M., Vidal H., Desreumaux P., Dubuquoy L., Bourreille A., Colombel J.F., Cherbut C., Galmiche J.P. Overexpression of leptin mRNA in mesenteric adipose tissue in inflammatory bowel diseases. Gastroenterol. Clin. Biol. 2003, 27:987-991.
4. Bokarewa M., Bokarew D., Hultgren O., Tarkowski A. Leptin consumption in the inflamed joints of patients with rheumatoid arthritis. Ann. Rheum. Dis. 2003, 62:952-956.
5. Bora P.S., Kaliappan S., Xu Q., Kumar S., Wang Y., Kaplan H.J., Bora N.S. Alcohol linked to enhanced angiogenesis in rat model of neovascularization. FEBS J. 2006, 273:1403-1414.
6. Bora P.S., Kaliappan S., Lyzogubov V.V., Tytarenko R.G., Thotakura S., Viswanathan T., Bora N.S. Expression of adiponectin in choroidal tissue and inhibition of laser induced choroidal neovascularization by adiponectin. FEBS Lett. 2007, 581:1977-1982.
7. Busso N., So A., Chobaz-Peclat V., Morard C., Martinez-Soria E., Talabot-Ayer D., Gabay C. Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J.Immunol. 2002, 168:875-882.
8. Considine R.V., Caro J.F. Leptin and the regulation of body weight. Int. J. Biochem. Cell. Biol. 1997, 29:1255-1272.
9. D'Amico D.J. Clinical practice. Primary retinal detachment. N.Engl. J. Med. 2008, 359:2346-2354.
10. De Jager W., Rijkers G.T. Solid-phase and bead-based cytokine immunoassay: a comparison. Methods 2006, 38:294-303.
11. Ehling A., Schäffler A., Herfarth H., Tarner I.H., Anders S., Distler O., Paul G., Distler J., Gay S., Schölmerich J., Neumann E., Müller-Ladner U. The potential of adiponectin in driving arthritis. J.Immunol. 2006, 176:4468-4478.
12. Evereklioglu C., Inalöz H.S., Kirtak N., Doganay S., Bülbül M., Ozerol E., Er H., Ozbek E. Serum leptin concentration is increased in patients with Behçet's syndrome and is correlated with disease activity. Br. J. Dermatol. 2002, 147:331-336.
13. Frank S., Stallmeyer B., Kampfer H., Kolb N., Pfeilschifter J. Leptin enhances wound re-epithelialization and constitutes a direct function of leptin in skin repair. J.Clin. Invest. 2000, 106:501-509.
14. Friedman J.M., Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 1998, 395:763-770.
15. Frübeck G. Intracellular signalling pathways activated by leptin. Biochem. J. 2006, 393:7-20.
16. Gariano R.F., Nath A.K., D'Amico D.J., Lee T., Sierra-Honigmann M.R. Elevation of vitreous leptin in diabetic retinopathy and retinal detachment. Invest. Ophthalmol. Vis. Sci. 2000, 41:3576-3581.
17. Hietaharju A., Kuusisto H., Nieminen R., Vuolteenaho K., Elovaara I., Moilanen E. Elevated cerebrospinal fluid adiponectin and adipsin levels in patients with multiple sclerosis: a Finnish co-twin study. Eur. J. Neurol. 2010, 17:332-334.
18. Hollborn M., Francke M., Iandiev I., Bühner E., Foja C., Kohen L., Reichenbach A., Wiedemann P., Bringmann A., Uhlmann S. Early activation of inflammation- and immune response-related genes after experimental detachment of the porcine retina. Invest. Ophthalmol. Vis. Sci. 2008, 49:1262-1273.
19. Im E., Kazlauskas A. The role of cathepsins in ocular physiology and pathology. Exp. Eye Res. 2007, 84:383-388.
20. Juge-Aubry C.E., Henrichot E., Meier C.A. Adipose tissue: a regulator of inflammation. Best Pract. Res. Clin. Endocrinol. Metab. 2005, 19:547-566.
21. Kükner A., Colakoglu N., Serin D., Alagöz G., Celebi S., Kükner A.S. Effects of intraperitoneal vitamin E, melatonin and aprotinin on leptin expression in the guinea pig eye during experimental uveitis. Acta Ophthalmol. Scand. 2006, 84:54-61.
22. Lago F., Dieguez C., Gómez-Reino J., Gualillo O. The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev. 2007, 18:313-325.
23. Lai C.M., Shen W.Y., Constable I., Rakoczy P.E. The use of adenovirus-mediated gene transfer to develop a rat model for photoreceptor degeneration. Invest. Ophthalmol. Vis. Sci. 2000, 41:580-584.
24. Liu L., Yang P., He H., Lin X., Jiang L., Chi W., Zhao C., Zhou H. Leptin increases in Vogt-Koyanagi-Harada (VKH) disease and promotes cell proliferation and inflammatory cytokine secretion. Br. J. Ophthalmol. 2008, 92:557-561.
25. Lord G.M., Matarese G., Howard J.K., Baker R.J., Bloom S.R., Lechler R.I. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998, 394:897-901.
26. Lovren F., Pan Y., Quan A., Szmitko P.E., Singh K.K., Shukla P.C., Gupta M., Chan L., Al-Omran M., Teoh H., Verma S. Adiponectin primes human monocytes into alternative ant-inflammatory M2 macrophages. Am. J. Physiol. Heart Circ. Physiol. 2010, 299:H656-H663.
27. Maberley D., Cui J.Z., Matsubara J.A. Vitreous leptin levels in retinal disease. Eye 2006, 20:801-804.
28. Maheshwari A., Kurundkar A.R., Shaik S.S., Kelly D.R., Hartman Y., Zhang W., Dimmitt R., Saeed S., Randolph D.A., Aprahamian C., Datta G., Ohls R.K. Epithelial cells in fetal intestine produce chemerin to recruit macrophages. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 297:G1-G10.
29. Matarese G., Carrieri P.B., La Cava A., Perna F., Sanna V., De Rosa V., Aufiero D., Fontana S., Zappacosta S. Leptin increase in multiple sclerosis associates with reduced number of CD4 (+) CD25+ regulatory T cells. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:5150-5155.
30. Matsuo T., Okada Y., Shiraga F., Yanagawa T. TIMP-1 and TIMP-2 levels in vitreous and subretinal fluid. Jpn. J. Ophthalmol. 1998, 42:377-380.
31. Mietz H., Heimann K. Onset and recurrence of proliferative vitreoretinopathy in various vitreoretinal diseases. Br. J. Ophthalmol. 1995, 79:874-877.
32. Murad A., Nath A.K., Cha S.T., Demir E., Flores-Riveros J., Sierra-Honigmann M.R. Leptin is an autocrine/paracrine regulator of wound healing. FASEB J. 2003, 17:1895-1897.
33. Nakazawa T., Matsubara A., Noda K., Hisatomi T., She H., Skondra D., Miyahara S., Sobrin L., Thomas K.L., Chen D.F., Grosskreutz C.L., Hafezi-Moghadam A., Miller J.W. Characterization of cytokine responses to retinal detachment in rats. Mol. Vis. 2006, 12:867-878.
34. Otero M., Lago R., Gomez R., Lago F., Dieguez C., Gómez-Reino J.J., Gualillo O. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann. Rheum. Dis. 2006, 65:1198-1201.
35. Pastor J.C., de la Rúa E.R., Martín F. Proliferative vitreoretinopathy: risk factors and pathobiology. Prog. Retin. Eye Res. 2002, 21:127-144.
36. Presle N., Pottie P., Dumond H., Guillaume C., Lapicque F., Pallu S., Mainard D., Netter P., Terlain B. Differential distribution of adipokines between serum and synovial fluid in patients with osteoarthritis. Contribution of joint tissues to their articular production. Osteoarthritis Cartilage 2006, 14:690-695.
37. Rakoczy P.E., Mann K., Cavaney D.M., Robertson T., Papadimitreou J., Constable I.J. Detection and possible functions of a cysteine protease involved in digestion of rod outer segments by retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 1994, 35:4100-4108.
38. Rasouli N., Kern P.A. Adipocytokines and the metabolic complications of obesity. J.Clin. Endocrinol. Metab. 2008, 93:S64-S73.
39. Retina Society Terminology Committee The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 1983, 90:121-125.
40. Ricker L.J.A.G., Kijlstra A., De Jager W., Liem A.T.A., Hendrikse F., La Heij E.C. Chemokine levels in subretinal fluid obtained during scleral buckling surgery after rhegmatogenous retinal detachment. Invest. Ophthalmol. Vis. Sci. 2010, 51:4143-4150.
41. Ricker L.J.A.G., Kijlstra A., Kessels A.G.H., de Jager W., Liem A.T.A., Hendrikse F., LaHeij E.C. Interleukin and growth factor levels in subretinal fluid in rhegmatogenous retinal detachment: a case-control study. PLoS ONE 2011, 6:e19141.
42. Sanna V., Di Giacomo A., La Cava A., Lechler R.I., Fontana S., Zappacosta S., Matarese G. Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J.Clin. Invest. 2003, 111:241-250.
43. Schäffler A., Ehling A., Neumann E., Herfarth H., Tarner I., Schölmerich J., Müller-Ladner U., Gay S. Adipocytokines in synovial fluid. JAMA 2003, 290:1709-1710.
44. Schipper H.S., De Jager W., Van Dijk M.E.A., Meerding J., Zelissen P.M.J., Adan R.A., Prakken B.J., Kalkhoven E. Amultiplex immunoassay for human adipokine profiling. Clin. Chem. 2010, 56:1320-1328.
45. Sethi C.S., Bailey T.A., Luthert P.J., Chong N.H.V. Matrix metalloproteinase biology applied to vitreoretinal disorders. Br. J. Ophthalmol. 2000, 84:654-666.
46. Siegmund B., Lehr H.A., Fantuzzi G. Leptin: a pivotal mediator of intestinal inflammation in mice. Gastroenterology 2002, 122:2011-2025.
47. Stallmeyer B., Kampfer H., Podda M., Kaufmann R., Pfeilschifter J., Frank S.A. Novel keratinocyte mitogen: regulation of leptin and its functional receptor in skin repair. J.Invest. Dermatol. 2001, 117:98-105.
48. Sugano E., Tomita H., Ishiguro A., Isago H., Tamai M. Nitric oxide-induced accumulation of lipofuscin-like materials is caused by inhibition of cathepsin S. Curr. Eye Res. 2006, 31:607-616.
49. Symeonidis C., Diza E., Papakonstantinou E., Souliou E., Dimitrakos S.A., Karakiulakis G. Correlation of the extent and duration of rhegmatogenous retinal detachment with the expression of matrix metalloproteinases in the vitreous. Retina 2007, 27:1279-1285.
50. Taleb S., Clément K. Emerging role of cathepsin S in obesity and its associated diseases. Clin. Chem. Lab. Med. 2007, 45:328-332.
51. Tilg H., Moschen A.R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 2006, 6:772-783.
52. Webster L., Chignell A.H., Limb G.A. Predominance of MMP-1 and MMP-2 in epiretinal and subretinal membranes of proliferative vitreoretinopathy. Exp. Eye Res. 1999, 68:91-98.
53. Weigert J., Obermeier F., Neumeier M., Wanninger J., Filarsky M., Bauer S., Aslanidis C., Rogler G., Ott C., Schäffler A., Schölmerich J., Buechler C. Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's disease. Inflamm. Bowel Dis. 2010, 16:630-637.